Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
Historically,ipolar disorder was first described byE. D. and B. D.anilyxas a “man-made”, non-cerebral brain disorder.
Bipolar disorder is further evolved based onB.being the first to be classified as a man-made abnormal brain rash. D.anilyx first appeared in the 17th century and is still first recognized as a medication. Strattera works by increasing the amount of neurotransmitters in the brain, such as dopamine and serotonin. The medication helps improve mood, attention, and behavior. It may also increase norepinephrine, a neurotransmitter that plays a role in controlling mood and behavior.
Primary Use: man-made abnormal brain rash.It may be used for short-term treatment of excessive sweating, irritability, anxiety, impulsivity, and other symptoms associated with an abnormal brain function.
Secondary Uses:, mood and behavior problems (such as irritability, anxiety, impulsivity, and other symptoms associated with depression, anxiety, and obsessive-compulsive disorder (OCD) problems).It may be used in some cases of mania or in certain cases of depression.
In Treatment of Irresponsiveness
Atomoxetine is a brand-name selective norepinephrine reuptake inhibitor that works by balancing the levels of neurotransmitters in the brain. It increases norepinephrine levels in the brain, which helps improve mood, attention, and behavior. Norepinephrine is a neurotransmitter that regulates nerve function and may help some people with depression feel better. It is often prescribed for anxiety disorders and certain mental conditions.
Strattera is used to treat a wide range of conditions caused by levels of certain neurotransmitters in the brain. Although it is not a full-spectrum treatment, atomoxetine is thought to have fewer side effects than other antidepressants. For example, it can increase concentration and mood in some patients. It may also reduce the frequency of episodes of mania or depression.
Patients should be aware of the potential side effects and seek medical attention if their symptoms persist or worsen.
Strattera is available in the following formulations:
Strattera (atomoxetine) is a prescription medication primarily used to treat:
The dosage and strength of atomoxetine will vary depending on the condition it is used to treat and how severe it is used. Atomoxetine is usually administered once a day, in doses of 10 mg or 20 mg. Patients may take the medication with or without food, as needed. The maximum daily dose is 20 mg, but the frequency of doses may vary depending on the condition it are used to treat.
For most patients, atomoxetine is usually the first medication taken orally. It can also be the day or night before a medication is prescribed. The medication is usually taken with a meal, though patients may be advised to take a little more liquid or take a meal before taking the medication.
Strattera (atomoxetine) is available in the many liquid formulations that the company offers:
Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].
The global Atomoxetine HCL API market is experiencing significant growth, driven by several key factors:
North America is expected to hold the largest share of the global ADHD drugs market due to the rising prevalence. This is due to its well-established healthcare infrastructure and advanced treatment options like atomoxetine HCL[2].
Europe's ADHD drugs market is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.50% from 2024 to 2031, going up from 2024 to 2031 with increasing demand. The European region is expected to hold the largest share of the market due to its advanced healthcare facilities and growing patient awareness[2].
The Asia Pacific region is expected to have the largest market share due to its well-established healthcare infrastructure and growing patient awareness. The region's population and lifestyles are also expected to improve as many countries are incorporated into the market[1].
Latin America's ADHD drugs market is analyzed as a potential growth area due to the increasing prevalence of autoimmune diseases, including lupus. This region's population is also expanding, due to the adoption of over the counter medications like Atomoxetine HCL[4].
The increasing prevalence of ADHD is a major driver of the ADHD drugs market. As more ADHD cases are identified and treated, the demand for effective medications like Atomoxetine HCL is increasing[1].
Increased blood clot risk due to traumatic brain injury and kidney disease are also contributing to the demand for Atomoxetine HCL[2].
Drivers of the market growth are on the market:
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is a prescription medication intended for adult adult men with attention disorder and narcolepsy=\" electric shock therapy/extremization\" for the treatment of ADHD/EPIIDD. Atomoxetine is an non-stimulant drug for the treatment of ADHD/EPIIDD. Men taking ADHD/EPIIDD may take atomoxetine except in children. Atomoxetine is not approved to treat any other indication; patients must have a registered medical provider order; and an approved prescription. For more information, ask customer support at mailmeds.com.
Strattera is a brand name for atomoxetine, which is the generic version of atomoxetine. Atomoxetine is the brand name for the drug atomoxetine. Other brand names for the drug are Adderall, Flomax, Mylan, Tarka, and Atrovent.
Strattera is a time-release formulation, with a custom built tablet and capsule form. The tablet and capsule are oval-shaped, orange-red-Orange-brown, and the color of an ink. The outer shape makes the medication less appealing to certain ethnicities, as well as to certain individuals with a history of allergic reactions to certain medications. Strattera is taken orally, usually once or twice daily with water, with or without a meal. The recommended starting dose is around 50 milligrams (mg) once daily, once or twice daily. Patients may take Adderall, Mylan, Tarka, or Atrovent twice daily, and should take atomoxetine with a meal before taking it. Doctors advise not to take atomoxetine once daily.
Before taking atomoxetine, tell your doctor if you have taken any other medications, including prescription drugs for such as St. month pregnant. Atomoxetine can pass into breast milk. Because breast milk can be dangerous for men, your doctor may prescribe breast-feeding while taking atomoxetine. Tell your doctor if you are breastfeeding.
Before taking atomoxetine, tell your doctor if you are allergic to it, or if you have any other allergies. Atomoxetine can cause dizziness, especially when combined with alcohol. Patients with fainting or breathing difficulties should avoid using atomoxetine while taking atomoxetine medication. Atomoxetine can make some liver disease more easily treatableby the medical profession. If you have any kidney or liver problems, stop taking atomoxetine before you treat your condition.
Tell your doctor if you are pregnant, planning to become pregnant, or are breast-feeding. You should also be aware that atomoxetine may cause breast-feeding. Because breast-feeding is not recommended, your doctor should not start you on any new medication without discussing with you the risks and benefits of using atomoxetine.
Tell your doctor if you are using any new or following hormonal birth controls. Some forms of birth control can pass as a birth control product to your baby. If you are using any of the birth control, tell your doctor.
The most common side effects of taking atomoxetine are drowsiness, headache, dizziness, nausea, stomach upset, and sleepiness. If these last more than 4 hours, contact your doctor.
If you are using the capsule, shake the bottle well before each dose. Do not use more than one dose at a time. The dose given may need to be adjusted.
The recommended starting dose for atomoxetine is mg, taken as many times as necessary to no more than cause an adverse reaction. The maximum dose of atomoxetine for any time is 20 mg. The recommended dose for atomoxetine for most patients is 30 mg.
It is not possible to determine when an overdose of atomoxetine will occur. Atomoxetine is not intended to cure ADHD. It may be helpful to you to take a slow-release tablet twice daily. However, the recommended starting dose is 0.5 mg, taken twice daily at the same time each day. The recommended starting dose for atomoxetine for most patients is 1 mg, taken once or twice daily.
Because atomoxetine passes into breast milk, you should not breast-feed if you are breast-fed; you should not breast-feed if you are under 18 years of age. The milk-lactation rate of the infant is less than 1 percent per month.
| Prescription only Prescribed for ADHD, Bipolar disorder, Major Depressive Disorder (MDD). Atomoxetine may also be used for purposes not listed in this medication guide. | Strattera is used for its anti-anxiety properties. However, it is not recommended for managing depression due to potential side effects. Risperidone may be... |
| More about | |
| Ratings & Reviews | |
Acitretin is effective for some individuals with ADHD. Atomoxetine is usually used alone or with other medication. Risperidone may also be used for... | 23/04/2025 11:14 AM |
| Acetazolamide is effective for some individuals with ADHD. | |
| Aripiprazole is effective for some individuals with ADHD. Risperidone may also be... | |
| Aripiprazole is effective for some individuals with Attention Deficit Hyperactivity Disorder (ADHD). Atomoxetine may also be used for... | |
| Aripiprazole is effective for some individuals with Attention Deficit Disorder (ADHD). | |
| Atomoxetine may also be used... | |
| Atomoxetine is usually used... | |
| Adrenocortical Dysfunction is a serious condition that can cause extreme and sudden, abnormal movements, changes in heartbeat, or death. Symptoms of adrenocortical dyspnea include shortness of breath, tremors... | |
| Atomoxetine is effective for some individuals with Attention Deficit Disorder (ADHD). | |
Stade de France Pharmacy